Fosun Pharma and Ruizhi Pharma Reach Strategic Cooperation
November 26, 2025
Source: drugdu
63
On November 25th, Fosun Pharma and Ruizhi Pharma...A strategic cooperation framework agreement signing ceremony was held in Shanghai. Li Xiang, Senior Vice President and CEO of the Global R&D Center of Fosun Pharma , stated that in the future, leveraging the full-chain R&D service capabilities of Ruizhi Pharma , Fosun Pharma is expected to further improve the efficiency and quality of its drug development across various drug types, accelerate the transformation of innovative achievements, and consolidate its competitive advantage in the field of innovative medicine. At the same time, the cooperation between the two parties sets a benchmark for the industry with a "technology-driven innovation platform + service platform" model, which will help promote the efficient integration of upstream and downstream resources in the industry chain, contribute to improving the overall level of new drug development in China, and bring more high-quality treatment options to more patients.
https://finance.eastmoney.com/a/202511253574517765.html
By editor
Copyright©2025 Ddu. All rights reserved.
Read more on
- Breaking the Mold and Forging a New Path! From Insulin Technology Pioneer to Global Innovation Competitor December 4, 2025
- A subsidiary of Kingfriend Pharmaceutical Co., Ltd. has received FDA approval for its self-developed injectable dapavancin December 4, 2025
- Major ophthalmic new drug successfully completed Phase III trials December 4, 2025
- Simcere Pharmaceutical and Wangshan Wangshui have reached an exclusive licensing agreement for deuterium remidevir hydrobromide for new indications such as RSV infection December 4, 2025
- SAL0140 tablets approved for clinical trials for the treatment of chronic kidney disease December 4, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
